DexTech Medical Overview
- Founded
- 2004
- Status
- Public
- Employees
- 1
- Stock Symbol
- DEX
- Share Price
- $5.31
- (As of Tuesday Closing)
DexTech Medical General Information
Description
DexTech Medical AB develops candidate medications with applications within urological oncology, primarily for prostate cancer. Its medication candidates include GuaDex, OsteoDex, and SomaDex, among others. The company conducts operations in medical research with the development of new drug candidates mainly in urological oncology, but also other cancer diseases and for non-malignant diseases.
Contact Information
Primary Industry
Drug Discovery
Stock Exchange
SAT
Primary Office
- Box 389
- 751 06 Uppsala
- Sweden
+46 070-710 00 00
DexTech Medical Stock Performance
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $5.31 | $5.42 | $3.62 - $8.19 | $79.2M | 14.9M | 3.05K | -$0.05 |
DexTech Medical Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2020 | FY 2020 30-Jun-2020 | FY 2019 30-Jun-2019 | FY 2018 30-Jun-2018 |
|---|---|---|---|---|
| EV | 69,864 | 77,681 | 124,352 | 77,102 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (172) | (217) | (146) | (130) |
| Net Income | (766) | (800) | (913) | (1,060) |
| Total Assets | 1,318 | 1,430 | 2,418 | 2,298 |
| Total Debt | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
DexTech Medical Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial